Research Funding

  • August 5, 1999 - May 31, 2023 - Cancer Center Support Grant , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P30CA082103
  • May 1, 1984 - March 31, 2014 - Basic Research in Hematology and Oncology , Principal Investigator . Sponsor: NIH, Sponsor Award ID: T32DK007636
  • September 30, 1992 - November 30, 2013 - SPORE in Breast Cancer , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P50CA058207
  • September 25, 2000 - June 30, 2010 - UCSF PROSTATE CANCER SPORE , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: P50CA089520
  • June 10, 1997 - June 30, 2010 - Proteases in Cancer Biology and Drug Development , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: P01CA072006
  • February 1, 1996 - December 31, 2006 - TRANSFUSION BIOLOGY AND MEDICINE , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: P50HL054476
  • August 15, 1993 - July 31, 1997 - UROKINASE RECEPTOR IN PROSTATE DEVELOPMENT AND CANCER , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA059545
  • July 1, 1975 - June 30, 1996 - BLOOD BANKING SCIENCES AND RELATED PROGRAMS , Principal Investigator . Sponsor: NIH, Sponsor Award ID: T32HL007100
  • December 1, 1984 - November 30, 1993 - BIOSYNTHESIS AND GENETICS OF GLYCOPROTEINS IIB AND IIIA , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL033277
  • December 1, 1981 - November 30, 1992 - CELLULAR REGULATION OF BLOOD CLOTTING , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL021403
  • July 1, 1983 - September 29, 1989 - PROTEINASE-INHIBITOR REACTIONS IN CORNEAL ENDOTHELIUM , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01EY004882
  • December 1, 1980 - November 30, 1985 - MECHANISM OF ACTIVATION OF COAGULATION AND PLATELETS , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K04HL000802

Education

University of Wisconsin, Madison Madison, WI, B.S., 1962, Philosophy/Chemistry
University of PA, Philadelphia Philadelphia, PA, Biology
Thomas Jefferson Medical College Philadelphia, PA, M.D., 1967, Medicine

Honors & Awards

  • 1980
    Elected to American Society of Clinical Investigation
  • 1981
    Awarded Research Career Development Award, National Institutes of Health
  • 1989
    Elected to Association of American Physicians

Selected Publications

  1. Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer. JCI Insight. 2018 09 06; 3(17).  View on PubMed
  2. Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016 12 01; 126(12):4640-4653.  View on PubMed
  3. Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY. EAG2 potassium channel with evolutionarily conserved function as a brain tumor target. Nat Neurosci. 2015 Sep; 18(9):1236-46.  View on PubMed
  4. Ge F, Wang DD, Li L, Lin PP, Shuman MA. WITHDRAWN: Enhanced Detection and Phenotypic and Karyotypic in Situ Characterization of Circulating Tumor Cells. Am J Pathol. 2014 Oct 17.  View on PubMed
  5. Kadoch C, Li J, Wong VS, Chen L, Cha S, Munster P, Lowell CA, Shuman MA, Rubenstein JL. Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma. Clin Cancer Res. 2014 Feb 15; 20(4):1029-41.  View on PubMed
  6. Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E, Batchelor T, Krouwer H, Hwang J, Auerback G, Kadoch C, Lowell C, Munster P, Cha S, Shuman MA, Damon LE. Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood. 2013 Jan 31; 121(5):745-51.  View on PubMed
  7. Huang X, Dubuc AM, Hashizume R, Berg J, He Y, Wang J, Chiang C, Cooper MK, Northcott PA, Taylor MD, Barnes MJ, Tihan T, Chen J, Hackett CS, Weiss WA, James CD, Rowitch DH, Shuman MA, Jan YN, Jan LY. Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev. 2012 Aug 15; 26(16):1780-96.  View on PubMed
  8. Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012 Feb 15; 18(4):1146-55.  View on PubMed
  9. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012 Feb; 40(4):1695-707.  View on PubMed
  10. Sun C, Su KH, Valentine J, Rosa-Bauza YT, Ellman JA, Elboudwarej O, Mukherjee B, Craik CS, Shuman MA, Chen FF, Zhang X. Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors. ACS Nano. 2010 Feb 23; 4(2):978-84.  View on PubMed
  11. So AY, de la Fuente E, Walter P, Shuman M, Bernales S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 2009 Jun; 28(1-2):219-23.  View on PubMed
  12. Kadoch C, Dinca EB, Voicu R, Chen L, Nguyen D, Parikh S, Karrim J, Shuman MA, Lowell CA, Treseler PA, James CD, Rubenstein JL. Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model. Clin Cancer Res. 2009 Mar 15; 15(6):1989-97.  View on PubMed
  13. Rubenstein JL, Shen A, Batchelor TT, Kadoch C, Treseler P, Shuman MA. Differential gene expression in central nervous system lymphoma. Blood. 2009 Jan 01; 113(1):266-7; author reply 267-8.  View on PubMed
  14. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol. 2008 Jan 01; 26(1):96-105.  View on PubMed
  15. Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol. 2007 Apr 10; 25(11):1350-6.  View on PubMed
  16. Chan JM, Feraco A, Shuman M, Hernández-Díaz S. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809.  View on PubMed
  17. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006 May 01; 107(9):3716-23.  View on PubMed
  18. Tindall D, Horne FM, Hruszkewycz A, Mohla S, Shuman M, Wang Z, Kantoff P. Symposium on androgen action in prostate cancer. Cancer Res. 2004 Oct 01; 64(19):7178-80.  View on PubMed
  19. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med. 2004 Jan 26; 164(2):218-20.  View on PubMed
  20. Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol Chem. 2003 Feb; 384(2):257-66.  View on PubMed

Go to UCSF Profiles, powered by CTSI